Clinicopathologic and genetic characterization of traditional serrated adenomas of the colon

American Journal of Clinical Pathology

Volumn 138, Issue 3, 2012, Pages 356-366

  Fu, Baojin ^a   Yachida, Shinichi ^a,b   Morgan, Richard ^a   Zhong, Yi ^a   Montgomery, Elizabeth A ^a   Iacobuzio Donahue, Christine A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

BRAF; Colon polyp; KRAS; p53; Traditional serrated adenoma

Indexed keywords

BETA CATENIN; KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON TRADITIONAL SERRATED ADENOMA; COLORECTAL POLYP; DYSPLASIA; FEMALE; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MALE; MOLECULAR GENETICS; ONCOGENE K RAS; PRIORITY JOURNAL;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; COLONIC NEOPLASMS; COLONIC POLYPS; FEMALE; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS;

EID: 84865408888     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPVT7LC4CRPZSK     Document Type: Article

References (29)

1. Noffsinger AE. Serrated polyps and colorectal cancer: new pathway to malignancy. Annu Rev Pathol. 2009;4:343-364.
2. Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol. 2011;42:1-10.
3. Torlakovic EE, Gomez JD, Driman DK, et al.Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol. 2008;32:21-29.
4. Yantiss RK, Oh KY, Chen Y-T, et al.Filiform serrated adenomas: a clinicopathologic and immunophenotypic study of 18 cases. Am J Surg Pathol. 2007;31:1238-1245. (Pubitemid 47207129)
5. O'Brien MJ, Yang S, Mack C, et al.Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol. 2006;30:1491-1501. (Pubitemid 44808785)
6. Kanzaki H, Hirasaki S, Suzuki S, et al.Early stage of colonic adenocarcinoma associated with traditional serrated adenoma. Intern Med. 2007;46:1911-1914.
7. Sheridan TB, Fenton H, Lewin MR, et al.Sessile serrated adenomas with low- and high-grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions "caught in the act." Am J Clin Pathol. 2006;126:564-571. (Pubitemid 44498506)
8. Lee SK, Chang HJ, Kim TI, et al.Clinicopathologic findings of colorectal traditional and sessile serrated adenomas in Korea: a multicenter study. Digestion. 2008;77:178-183.
9. Kim KM, Lee EJ, Kim Y-H, et al.KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype. Am J Surg Pathol. 2010;34:667-675.
10. Yachida S, Mudali S, Martin SA, et al.Beta-catenin nuclear labeling is a common feature of sessile serrated adenomas and correlates with early neoplastic progression after BRAF activation. Am J Surg Pathol. 2009;33:1823-1832.
11. Bosman FT, Carneiro F, Hruban RH. WHO Classification of Tumours of the Digestive System. Geneva, Switzerland: World Health Organization; 2010.
12. Wu JM, Montgomery EA, Iacobuzio-Donahue CA. Frequent beta-catenin nuclear labeling in sessile serrated polyps of the colorectum with neoplastic potential. Am J Clin Pathol. 2008;129:416-423. (Pubitemid 352029294)
13. Fu X, Li J, Li K, et al.Hypermethylation of APC promoter 1A is associated with moderate activation of Wnt signalling pathway in a subset of colorectal serrated adenomas. Histopathology. 2009;55:554-563.
14. Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas: a distinct form of colorectal neoplasia. Am J Surg Pathol. 1990;14:524-537. (Pubitemid 20172523)
15. Jass JR, Baker K, Zlobec I, et al.Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a "fusion" pathway to colorectal cancer. Histopathology. 2006;49:121-131. (Pubitemid 44079695)
16. Torlakovic E, Skovlund E, Snover DC, et al.Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol. 2003;27:65-81. (Pubitemid 36014900)
17. Han Y, Zhou ZY. Clinical features and molecular alterations of traditional serrated adenoma in sporadic colorectal carcinogenesis. J Dig Dis. 2011;12:193-198.
18. Haramis A-PG, Begthel H, van den Born M, et al.De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science. 2004;303:1684-1686. (Pubitemid 38338329)
19. Baas IO, Mulder JW, Offerhaus GJ, et al.An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol. 1994;172:5-12. (Pubitemid 24074995)
20. Hiyama T, Yokozaki H, Shimamoto F, et al.Frequent p53 gene mutations in serrated adenomas of the colorectum. J Pathol. 1998;186:131-139. (Pubitemid 28467821)
21. Yang S, Farraye FA, Mack C, et al.BRAF and KRAS mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol. 2004;28:1452-1459. (Pubitemid 39425511)
22. Rosenberg DW, Yang S, Pleau DC, et al.Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans. Cancer Res. 2007;67:3551-3554. (Pubitemid 46762136)
23. Chan TL, Zhao W, Leung SY, et al.BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res. 2003;63:4878-4881. (Pubitemid 37022620)
24. Fujita K, Yamamoto H, Matsumoto T, et al.Sessile serrated adenoma with early neoplastic progression: a clinicopathologic and molecular study. Am J Surg Pathol. 2011;35:295-304.
25. Ngo NT, Tan E, Tekkis P, et al.Differential expression of p53 and p504s in hyperplastic polyp, sessile serrated adenoma and traditional serrated adenoma. Int J Colorectal Dis. 2010;25:1193-1200.
26. Huang CS, Farraye FA, Yang S, et al.The clinical significance of serrated polyps. Am J Gastroenterol. 2011;106:229-240;quiz 241.
27. Haigis KM, Kendall KR, Wang Y, et al.Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon. Nat Genet. 2008;40:600-608. (Pubitemid 351601205)
28. Feng Y, Bommer GT, Zhao J, et al.Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool. Gastroenterology. 2011;141:1003-1013.
29. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759-767.